Pulling verified daily bars for this ticker.
Recent earnings
1/4
quarters beat
Big funds
8
hold this stock
News tone
Bullish
43 articles, 7 days
Analysts
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsWhat it reported, what was expected, and what comes next.
Reported Aug 6, 2026
Earnings per share
-$0.47 expected
Revenue
$661.3M expected
The release did not provide a source-backed EPS figure.
2026 guidance
$2.85B to $2.91B
No comparable estimate
Next report
EPS expected
-$0.22 to -$0.22
Revenue expected
17 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
From the release
The three statements, quarter by quarter.
Sep 2025 to Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| RevenueTotal revenue | $592.2M | $665.5M | $696.6M | $752.8M |
| Cost of what it soldCost of revenue | $207.8M | $218.7M | $245.2M | $267.6M |
| Gross profit | $384.4M | $446.8M | $451.4M | $485.2M |
| What it spent | ||||
| Research and development | $173.4M | $175.2M | $210.7M | $228.1M |
| Sales and adminSelling, general and administrative | $308.5M | $291.3M | $327.9M | $327.2M |
| Other operating costsOperating costs not itemised in the filing's summary | — | — | $6.3M | $5.7M |
| Total operating expenses | $482.0M | $469.6M | $545.0M | $561.0M |
| What was left | ||||
| Operating profitOperating income | -$97.6M | -$22.8M | -$93.5M | -$75.8M |
| Interest on debtInterest expense | $1.0M | $7.1M | $892.0K | $890.0K |
| Profit before tax | -$87.3M | -$13.3M | -$84.8M | -$67.2M |
| TaxIncome tax expense | $207.0K | -$60.6M | $283.0K | -$261.0K |
| Net profitNet income | -$87.5M | $47.3M | -$85.1M | -$67.0M |
| EBITDAEarnings before interest, tax, depreciation, amortisation | -$76.4M | $7.9M | -$65.5M | -$45.2M |
Business quality, value, and expectations at a glance.
Fundamentals
This company is not yet profitable.
Valuation
Quality
Growth
Filed positions and reported activity tied to this stock.
8 funds hold a position and insiders have been net selling.
Real smart money
Insiders
Trend, range, and the price levels that matter.
Technicals
Technicals sync when verified market data is available. No sample data is shown.
Recent coverage and its overall tone.
News
Coverage leans bullish
18 bullish · 19 neutral · 6 bearish
Tone of tracked coverage
NTRA Maintained by Guggenheim -- Price Target Raised to $360
Leans bullishAug 12Natera partners with Kupando for phase 1 cancer trial in Germany
BullishAug 12First Patient Dosed as Trial Tests Immunotherapy in Skin Cancers
BullishAug 12Should You Worry That a Natera Co-Founder Sold Shares? Here's What Long-Term Investors Should Know
BullishAug 11Should You Worry That a Natera Co-Founder Sold Shares? Here's What Long-Term Investors Should Know
Leans bullishAug 11A Natera Co-Founder Sold Into Record Highs. Here's What Long-Term Investors Should Know
NeutralAug 10Natera Stock Jumps As Q2 Beat Triggers Target Hikes
BullishAug 8Natera, Inc. Stock 12‑Month Price Target Raised to $317.33, Implies 20% Upside
BullishAug 8
AlphaYou
